Prevention of COVID-19 Infection to Severe Pneumonia or ARDS | MicrobiomeTrials← Back to trialsNCT04569227
Prevention of COVID-19 Infection to Severe Pneumonia or ARDS
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-12-30Est. Completion: 2027-12-30
Enrollment target: 60 participants Locations- Lincoln Medical Center, The Bronx, New York, United States
- Kent County Memorial Hospital, Warwick, Rhode Island, United States
Other microbiome trials you might be interested in
SARS-CoV-2
The primary purpose of this study is to evaluate the efficacy and safety of secutrelvir in symptomatic nonhospitalized a…
Coral Gables, United StatesEst. completion Jun 30, 2028
Anogenital HerpesCOVID-19Herpes Labialis
Background:
\- Viral infections are an important cause of illness and death in hospitalized patients as well as outpati…
Bethesda, United States
Phase 2
TERMINATED
COVID-19 patients who develop severe disease often develop acute respiratory distress syndrome (ARDS) as a result of a d…
Fresno, United StatesCompleted Jul 22, 2024